Mankind Pharma (MANKIND.NS) Financial Analysis & Valuation | Quarter Chart

Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer healthcare products primarily in India and internationally. The company develops pharmaceuticals for acute and chronic therapeutics in the areas of anti-infective, cardiovascular, gastrointestinal, an... more
Mankind Pharma Limited develops, manufactures, and markets pharmaceutical formulations and consumer ... more

Company facts

Reported company information and share structure.

Company Share structure
Market Cap$10.65BExchangeNSE
SectorHealthcareIndustryDrug Manufacturers - Specialty & Generic
CountryINCEOSheetal Arora
IPO Date2023-05-09CAGR16.24%
Employees19,540Websitewww.mankindpharma.com
Div. Yield0.04%Payout Ratio2%
Buy Back Yield—Total Yield0.04%
MANKIND.NS chart loading...

Key metrics

Reported fundamentals and market-derived technical indicators.

Fundamentals Technicals
Enterprise Value$885.76BP/E Ratio50.29
Forward P/E34.86PEG Ratio1.69
P/S Ratio12.93P/B Ratio11.28
P/CF Ratio112.45P/FCF Ratio134.9
EPS$0.51EPS Growth 1Y-6.28%
EPS Growth 3Y44.63%EPS Growth 5Y—
Revenue Growth 1Y17.65%Gross Margin0.57%
Operating Margin0.19%Profit Margin0.13%
ROE0.13%ROA0.07%
ROCE0.13%Current Ratio1.07
Quick Ratio0.74Cash Ratio0.07
Debt/Equity0.39Interest Coverage4.27
Altman Z Score6.15Piotroski Score3

View Mankind Pharma financial charts →

Mankind Pharma (MANKIND.NS) valuation & financials

Mankind Pharma (MANKIND.NS) has a market capitalization of 10.65B INR and trades at a price-to-earnings ratio of 50.3. It operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).

Mankind Pharma's revenue grew +17.7% over the last year.

Mankind Pharma's next earnings report is scheduled for June 2, 2026; analysts estimate EPS of 0.14 INR.

📈 Analysts estimate MANKIND.NS EPS of 0.14 INR for the upcoming quarter. See Mankind Pharma revenue & EPS analyst forecasts for the next four quarters with Quarter Chart Premium.

Mankind Pharma (MANKIND.NS) — frequently asked questions

When does Mankind Pharma (MANKIND.NS) report earnings next?

Mankind Pharma is expected to report earnings on June 2, 2026. Analysts estimate EPS of 0.14 INR.

What is Mankind Pharma's market cap?

Mankind Pharma (MANKIND.NS) has a market capitalization of 10.65B INR.

What is MANKIND.NS's P/E ratio?

Mankind Pharma trades at a price-to-earnings ratio of 50.3, with trailing twelve-month EPS of 0.51 INR.

How fast is Mankind Pharma growing?

Mankind Pharma's revenue grew +17.7% over the last year.

Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · UnitedHealth (UNH) · Roche (ROG.SW) · Merck (MRK)

Mankind Pharma revenue & earnings charts →